GlassScriptPhysician profile
Edgar W Hull
NPI 1063628808
$2,269.83
in general payments reported to CMS, 2019-2025
32 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,831 · 2020: $405 · 2021: $33.54.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $327.21 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $289.93 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $199.63 | 2019-2020 | |
| Janssen Biotech, INC. | $175.04 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $132.49 | 2019-2020 | |
| Pharmacyclics LLC, An Abbvie Company | $100.07 | 2019-2021 | |
| Amgen INC. | $98.31 | 2019-2020 | |
| Astellas Pharma US INC | $91.94 | 2019-2020 | |
| Celgene Corporation | $88.51 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $69.02 | 2019 | |
| Incyte Corporation | $65.81 | 2019 | |
| Genzyme Corporation | $59.06 | 2019-2020 | |
| Abbvie INC. | $56.79 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $51.24 | 2019-2020 | |
| Daiichi Sankyo INC. | $49.31 | 2019-2020 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $48.89 | 2019-2020 | |
| Genentech USA, INC. | $45.52 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $43.11 | 2019-2020 | |
| Verastem, INC. | $42.75 | 2019-2020 | |
| Emd Serono, INC. | $29.43 | 2019 | |
| Seagen INC. | $27.52 | 2019-2020 | |
| Tesaro, INC. | $27.09 | 2019 | |
| Puma Biotechnology, INC. | $24.04 | 2019 | |
| Biocompatibles, INC. | $17.79 | 2019 | |
| Coherus Oncology, INC. | $16.98 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $13.86 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.76 | 2019 | |
| Dova Pharmaceuticals | $13.49 | 2019 | |
| Myriad Genetic Laboratories, INC. | $13.29 | 2019 | |
| Pharmacosmos Therapeutics INC. | $13.03 | 2021 | |
| Eusa Pharma (US) LLC | $12.85 | 2019 | |
| Lilly USA, LLC | $12.07 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edgar Hull listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.